Korro Bio
(NASDAQ) KRRO
Korro Bio Financials at a Glance
Market Cap
$185.91M
Revenue (TTM)
$6.39M
Net Income (TTM)
$117.26M
EPS (TTM)
$-12.48
P/E Ratio
-1.03
Dividend
$0.00
Beta (Volatility)
1.44 (Average)
Dividend
$0.00
Beta (Volatility)
1.44 (Average)
Price
$12.80
Volume
3,947
Open
$12.86
Price
$12.80
Volume
3,947
Open
$12.86
Previous Close
$12.80
Daily Range
$12.75 - $13.43
52-Week Range
$5.20 - $55.89
Dividend
$0.00
Beta (Volatility)
1.44 (Average)
Price
$12.80
Volume
3,947
Open
$12.86
Previous Close
$12.80
Daily Range
$12.75 - $13.43
52-Week Range
$5.20 - $55.89
KRRO News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Korro Bio
Industry
Biotechnology
Sector
Health CareEmployees
58
CEO
Ram Aiyar, PhD, MBA
Website
www.korrobio.comHeadquarters
Cambridge, MA 02139-1562, US
KRRO Financials
Key Financial Metrics (TTM)
Gross Margin
90%
Operating Margin
-14%
Net Income Margin
-18%
Return on Equity
-111%
Return on Capital
-86%
Return on Assets
-1%
Earnings Yield
-97.09%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$185.91M
Shares Outstanding
14.42M
Volume
3.95K
Short Interest
0.00%
Avg. Volume
230.95K
Financials (TTM)
Gross Profit
$2.11M
Operating Income
$87.34M
EBITDA
$83.06M
Operating Cash Flow
$78.56M
Capital Expenditure
$518.00K
Free Cash Flow
$79.08M
Cash & ST Invst.
$75.16M
Total Debt
$43.49M
Korro Bio Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$1.29M
-43.1%
Gross Profit
$643.00K
-71.7%
Gross Margin
49.77%
N/A
Market Cap
$185.91M
N/A
Market Cap/Employee
$1.66M
N/A
Employees
112
N/A
Net Income
$50.04M
-136.1%
EBITDA
$15.23M
+30.1%
Quarterly Fundamentals
Net Cash
$31.67M
-61.1%
Accounts Receivable
$969.00K
-42.9%
Inventory
$0.00
N/A
Long Term Debt
$40.81M
-6.1%
Short Term Debt
$2.67M
+108.1%
Return on Assets
-1.03%
N/A
Return on Invested Capital
-85.99%
N/A
Free Cash Flow
$17.79M
-98.8%
Operating Cash Flow
$17.70M
-136.2%